In line with this finding, we previously reported that in skin lesions of SSc, the TGF-β pathway was enhanced in the CENT+ group and IFN signaling was enhanced in patients with positive antibodies to U1 ribonucleoprotein, one of the RBPs34. Here, TGFB1 is linked to systemic sclerosis.